The Role of Cardiac Surgeons in Transcatheter Structural Heart Disease Interventions
Author Department
Medicine; Cardiology
Document Type
Article, Peer-reviewed
Publication Date
10-2024
Abstract
Background: With the rapid growth and evolution of transcatheter valve therapies, surgeons are foreseeing a crucial change in their practice. Their role is rapidly evolving and the concept of a structured heart valve team is becoming central in every established SHD program. The knowledge and expertise of surgeons is adapting to a novel and revolutionized field of transcatheter valve therapies, where a multidisciplinary approach is crucial for optimal outcomes and patient satisfaction. This manuscript aims to discuss the evolving role of surgeons in structural heart interventions METHODS: We depict the importance of the heart valve team and outline the challenges surgeons are facing to establish themselves as structural heart operators.
Results: The switch in clinical practice surgeons are experiencing is extremely important for the future of cardiac surgery. The results of a globally conducted real-world survey shows that despite 97% of surgeons are active members of the heart team, 80% take part to TAVR procedures, and the percentage drops significantly in mitral and tricuspid interventions.
Conclusions: Surgeons need to evolve, adapt and embrace this new patient-centered paradigm and broaden their skills and competences maintaining a primary role in the treatment of valvular heat pathologies.
Keywords: TAVR; TEER; catheter; heart team; hybrid; valves.
Recommended Citation
Pirelli L, Grubb KJ, George I, Goldsweig AM, Nazif TM, Dahle G, Myers PO, Ouzounian M, Szeto WY, Maisano F, Geirsson A, Vahl TP, Kodali SK, Kaneko T, Tang GHL. The Role of Cardiac Surgeons in Transcatheter Structural Heart Disease Interventions. J Thorac Cardiovasc Surg. 2024 Oct 26:S0022-5223(24)00989-9. doi: 10.1016/j.jtcvs.2024.10.037. Epub ahead of print.
PMID
39490524